Psychopathological Risk Factors Associated With Conversion From Mild Cognitive Impairment to Dementia (FPRMCI)
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Background: Dementias (Alzheimer's disease and related syndromes), in their sporadic form, have multifactorial origin. Several risk factors (RF) are currently recognized like the cardiovascular RF, some genes of susceptibility, but the impact [1] of traumatic life events (TLE), considered as psychosocial RF (Persson & Skoog, 1996; Charles et al, 2006), [2] of anxiety and/or depression, [3] of the premorbid personality (Clément et al, 2003) with his coping strategies, and [4] of the lifestyle (which results from the personality), for the moment are still underestimated. Dementia disease can be clinically preceded by a mild cognitive impairment (MCI) (Petersen et al, 1996) which is however potentially reversible.
Purpose: Actually, there is no study concerning the rate of conversion from MCI to dementia according to the presence or not of TLE. The aim of this study is to assess association between TLE and conversion rate from MCI to dementia.
Methods: Patients with MCI will be recruited in different memory clinics (Limoges and others) Primary outcome: Occurrence of dementia according to DSM-IV-TR criteria in MCI patients according to their cumulated score of TLE measured by EVVIE.
Secondary outcomes: Occurrence of dementia in MCI patients according to various other psychopathological factors: anxiety, depression, apathy, personality features, alexithymia and resilience levels and life style.
Study design: Epidemiologic cohort longitudinal and prospective multicenter study.
| Condition |
|---|
|
Mild Cognitive Impairment |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Prospective |
| Official Title: | Psychopathological Risk Factors Associated With Conversion From Mild Cognitive Impairment to Dementia |
- Occurrence of dementia according to DSM-IV-TR criteria in MCI patients according to their cumulated score of TLE measured by EVVIE. [ Time Frame: 2 years ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 392 |
| Study Start Date: | February 2010 |
| Estimated Study Completion Date: | February 2014 |
| Estimated Primary Completion Date: | February 2012 (Final data collection date for primary outcome measure) |
Eligibility criteria:
Inclusion criteria:
- Man or woman ≥ 50 years.
- Patient with MCI, of any type, according to the criteria of Petersen et al, 2001.
- Clinical Dementia Rating (CDR) ≤ 0,5.
- Instrumental activities of daily living (IADL)=0.
- MMSE > 26.
- Cognitive and functional capacities well enough in order to avoid a possible diagnosis of Alzheimer's disease based on clinical evidences (DSM-IV TR) cannot be done during initial visit.
- Ambulatory patient.
- Visual and auditory capabilities (equipment allowed) and oral or written capacity able for the development of suitable tests (according to the clinician).
exclusion criteria:
- Patient with identified neurological problems.
- Patient with developing and/ or non-stabilized psychiatric disease.
- Patient with biological disorders observed during diagnostic process. Number of subjects: 392 subjects Statistical analysis: Statistical analyses will be performed by the Unité Fonctionnelle de Recherche Clinique et de Biostatistique from the Limoges teaching hospital using SAS® V 9.1.3 software (SAS Institute Cary, NC). Level of significance will be 0.05 for all analyses. Statistical analyses will be performed and presented in agreement with STROBE guidelines.
Descriptive analyses
Quantitative variables will be described using mean ± standard deviation or median and interquartile range. Qualitative variables will be described using frequencies, percentages and 95% confidence intervals assessed with exact method.
A flow chart of patients will be presented.
Main analysis Association between dementia and EVVIE score will be assessed through relative risk calculation. 95% confidence interval will also be calculated.
Eligibility| Ages Eligible for Study: | 50 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Probability Sample |
Patients with MCI will be recruited in different memory clinics (Limoges and others)
Inclusion Criteria:
- Man or woman ≥ 50 years.
- Patient with MCI, of any type, according to the criteria of Petersen et al, 2001.
- Clinical Dementia Rating (CDR) ≤ 0,5.
- Instrumental activities of daily living (IADL)=0.
- MMSE > 26.
- Cognitive and functional capacities well enough in order to avoid a possible diagnosis of Alzheimer's disease based on clinical evidences (DSM-IV TR) cannot be done during initial visit.
- Ambulatory patient.
- Visual and auditory capabilities (equipment allowed) and oral or written capacity able for the development of suitable tests (according to the clinician).
Exclusion Criteria:
- Patient with identified neurological problems.
- Patient with developing and/ or non-stabilized psychiatric disease.
- Patient with biological disorders observed during diagnostic process.
Contacts and Locations| France | |
| CH Esquirol | Recruiting |
| Limoges, France, 87025 | |
| Contact: Annie Druet-Cabanac, PhD +33555431215 aniejean@hotmail.com | |
| Sub-Investigator: Benjamin Calvet, MD | |
| Sub-Investigator: Leslie Cartz-Piver, MD | |
| Sub-Investigator: Laurence Bernard-Bourzeix, MD | |
| Principal Investigator: | Jean-Pierre Clement, MD, PhD | CH Esquirol |
More Information
No publications provided
| Responsible Party: | Jean Pierre Clement, Professor of Psychiatry -Ph.D, Centre Hospitalier Esquirol |
| ClinicalTrials.gov Identifier: | NCT01436552 History of Changes |
| Other Study ID Numbers: | B1001104-10 |
| Study First Received: | September 16, 2011 |
| Last Updated: | September 16, 2011 |
| Health Authority: | France: Committee for the Protection of Personnes |
Keywords provided by Centre Hospitalier Esquirol:
|
MCI Depression Alzheimer Life events |
Additional relevant MeSH terms:
|
Dementia Cognition Disorders Brain Diseases Central Nervous System Diseases |
Nervous System Diseases Delirium, Dementia, Amnestic, Cognitive Disorders Mental Disorders |
ClinicalTrials.gov processed this record on May 22, 2013